Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
BMC Medical Genetics|November 9, 2002
Telomerase activity in human leukemic cells with or without monosomy 7 or 7q-Nedime Serakinci, Jørn E KochMultidisciplinary Respiratory Medicine|October 29, 2020
Updated North Cyprus response status for COVID-19 in comparison with similar country sizes. Highlights on the importance of population per square meterNedime Serakinci, Ahmet Savasan, Finn RasmussenHealthcare (Basel, Switzerland)|July 26, 2020
Risk Prediction Model Development for Late On-Set Breast Cancer Screening in Low- and Middle-Income Societies: A Model Study for North CyprusCeasar Dubor Danladi, Nedime SerakinciBiochimie|November 22, 2007
Telomere stability and telomerase in mesenchymal stem cellsNedime Serakinci, Jesper Graakjaer, Steen KolvraaJournal of Biosocial Science|May 16, 2017
PRACTICE OF CONSANGUINITY AND ATTITUDES TOWARDS RISK IN THE PASHTUN POPULATION OF KHYBER PAKHTUNKHWA, PAKISTANRuqiya Pervaiz, Faisal Faisal, Nedime SerakinciBMC Blood Disorders|June 24, 2004
A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal HaemoglobinuriaW Nicol Keith, Tom Vulliamy, Jiangqin Zhao, et al.Current Stem Cell Research & Therapy|February 3, 2016
Double faced role of human mesenchymal stem cells and their role challenges in cancer therapyNedime Serakinci, Rasime Kalkan, Pinar TulayMethods in Molecular Biology (Clifton, N.J.)|March 16, 2018
Use of U-STELA for Accurate Measurement of Extremely Short TelomeresNedime Serakinci, Huseyin Cagsin, Merdiye MavisAdvances in Experimental Medicine and Biology|July 22, 2017
Role of Mesenchymal Stem Cells in Cancer Development and Their Use in Cancer TherapyNedime Serakinci, Pinar Tulay, Rasime KalkanEuropean Journal of Cancer (Oxford, England : 1990)|March 12, 2014
Mesenchymal stem cells, cancer challenges and new directionsNedime Serakinci, Umut Fahrioglu, Rikke ChristensenPageof 8